Close
Help
Need Help?



Drug Target Insights


217,447 Journal Article Views

Submit a Paper

Editor in Chief: Prithviraj Bose

Aims & Scope: Drug Target Insights covers current developments in all areas of the field of clinical therape... more

Indexing: Pubmed, Chemical Abstracts Service, Chinese Electronic Periodical Service, Directory of Open Access Journals, EBSCO Academic Search Complete, EMBase, Gale Academic OneFile, Gale Health Reference Centre, Gale InfoTrac Custom Journals, Index Copernicus, Intute, OAlster, ProQuest Health & Medical Complete, Pubmed Central, Socolar

Directories: Academic Journals Database, EBSCO A-Z, HINARI, JournalSeek, JournalTOCs, OAJSE, Pubshub, ScientificCommons, Scirus, Ulrich's Periodicals

Processing Speed: Editorial decision less than 3 weeks, publication in average 3 weeks after acceptance

ISSN: 1177-3928

Prithviraj Bose

Dr. Bose is an Assistant Professor of Medicine in the Division of Hematology, Oncology and Palliative Care at Virginia Commonwealth University in Richmond, VA. After obtaining his medical degree from Calcutta Medical College in India, he completed a residency in internal medicine at Henry Ford Hospital in Detroit, MI and a fellowship in hematology and oncology from the University of Oklahoma Health Sciences Center in Oklahoma City, OK.

Dr. Bose is a clinical and translational researcher whose primary focus is on the acute leukemias and other myeloid neoplasms. Specifically, he designs early phase clinial trials involving novel combinations of targeted agents. He sees patients with a diverse range of malignant hematologic conditions at the National Cancer Institute-designated VCU Massey Cancer Center. He is also actively involved in the education of hematology/oncology trainees. Dr. Bose is an avid scientific writer and has authored several important clinical articles in leading peer-reviewed journals. He continues to be active in publishing his research findings, review articles and book chapters.

>> Dr Bose's latest call for papers

profile details Email Address: Twitter: http://twitter.com/drugtargets

Our Service Promise

  • Prompt Processing (3 Weeks to Editorial Decision)
  • Fair, Independent Peer Review
  • High Visibility & Extensive Indexing
What Your Colleagues Say About Drug Target Insights
I have had contact with Drug Target Insights several times, and every time I am impressed by the handling of the manuscript. The website is very, very user-friendly. It is easy to submit a manuscript.  The entire process is easy and straightforward.  The corresponding author is kept updated on the progress at every point.  The editors of Libertas were helpful and prompt in responding to questions and issues related to the submission I am pleased ...
Dr Bodil Ohlsson (Lund University, Sweden)
More Testimonials

Quick Links

SUBJECT HUBS
Author Survey Results
author_survey_results
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.
See Our Results